Skip to main content
Erschienen in: Clinical Rheumatology 3/2021

23.10.2020 | Brief Report

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?

verfasst von: Tracy M. Frech, John M. VanBuren, Emily Startup, Shervin Assassi, Elana J. Bernstein, Flavia V. Castelino, Lorinda Chung, Chase Correia, Jessica K. Gordon, Faye N. Hant, Laura Hummers, Dinesh Khanna, Nora Sandorfi, Ami A. Shah, Victoria K. Shanmugam, Virginia Steen, Luke Evnin

Erschienen in: Clinical Rheumatology | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

The objective of this analysis is to examine whether the severity of systemic sclerosis (SSc)-hand involvement influences patient-reported outcome measure (PROM) completion rate in a US cohort of early disease. Participants included SSc patients with less than 5 years disease duration consented and enrolled in the Collaborative, National, Quality, and Efficacy Registry (CONQUER) between June 2018 and December 2019. Participants’ socio-demographics, hand clinical features (severe modified Rodnan skin score, presence of small joint contractures, acro-osteolysis, calcinosis, and digital ulcers), and completion rates of seven PROMs including a Resource Use Questionnaire were analyzed. Cohort characteristics and baseline PROM completion were evaluated. Multivariable logistic regression assessed the relationship between hand limitations and PROM incompletion at several time points using generalized estimating equations. At the time of data lock, 339 CONQUER subjects had a total of 600 visits available for analysis. Calcinosis (odds ratio [OR] 6.35, confidence interval [CI] 2.41–16.73 and acro-osteolysis OR 3.88 (1.57–9.55) were significantly associated with incomplete PROM. The Resource Use Questionnaire was the PROM most commonly not completed. Increasing age was correlated with resource use questionnaire incompletion rate. Acro-osteolysis and calcinosis were associated with lower PROM completion rates in a US SSc cohort, independent of the length of the questionnaires or the modality of administration (electronic or paper). Resource Use Questionnaires are important for understanding the economic impact and burden of chronic disease; however, in this study, it had lower completion rates than PROMs devoted to clinical variables.
Key points
Multiple strategies are needed to ensure optimal completion of PROM in longitudinal cohort studies. Even if patients request electronic surveys, we have found it is important to follow up incomplete surveys with paper forms provided at the time of a clinical visit.
The Resource Utilization Questionnaire was lengthy and prone to non-completion in the younger population.
Acro-osteolysis and calcinosis were associated with reduced PROM completion rates.
Literatur
1.
Zurück zum Zitat Leggett LE, Khadaroo RG, Holroyd-Leduc J, Lorenzetti DL, Hanson H, Wagg A et al (2016) Measuring resource utilization: a systematic review of validated self-reported questionnaires. Medicine (Baltimore) 95(10):e2759CrossRef Leggett LE, Khadaroo RG, Holroyd-Leduc J, Lorenzetti DL, Hanson H, Wagg A et al (2016) Measuring resource utilization: a systematic review of validated self-reported questionnaires. Medicine (Baltimore) 95(10):e2759CrossRef
2.
Zurück zum Zitat Slade A, Isa F, Kyte D, Pankhurst T, Kerecuk L, Ferguson J et al (2018) Patient reported outcome measures in rare diseases: a narrative review. Orphanet J Rare Dis 13(1):61CrossRef Slade A, Isa F, Kyte D, Pankhurst T, Kerecuk L, Ferguson J et al (2018) Patient reported outcome measures in rare diseases: a narrative review. Orphanet J Rare Dis 13(1):61CrossRef
3.
Zurück zum Zitat Snyder CF, Watson ME, Jackson JD, Cella D, Halyard MY, Mayo FDAP-ROCMG (2007) Patient-reported outcome instrument selection: designing a measurement strategy. Value Health 10 Suppl 2:S76–S85CrossRef Snyder CF, Watson ME, Jackson JD, Cella D, Halyard MY, Mayo FDAP-ROCMG (2007) Patient-reported outcome instrument selection: designing a measurement strategy. Value Health 10 Suppl 2:S76–S85CrossRef
4.
Zurück zum Zitat Shanmugam VK, Frech TM, Steen VD, Hummers LK, Shah AA, Bernstein EJ et al (2020) Collaborative National Quality and Efficacy Registry (CONQUER) for scleroderma: outcomes from a multicenter US-based systemic sclerosis registry. Clin Rheumatol 39(1):93–102CrossRef Shanmugam VK, Frech TM, Steen VD, Hummers LK, Shah AA, Bernstein EJ et al (2020) Collaborative National Quality and Efficacy Registry (CONQUER) for scleroderma: outcomes from a multicenter US-based systemic sclerosis registry. Clin Rheumatol 39(1):93–102CrossRef
5.
Zurück zum Zitat Pope J (2011) Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS). Arthritis Care Res (Hoboken) 63 Suppl 11:S98–S111CrossRef Pope J (2011) Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS). Arthritis Care Res (Hoboken) 63 Suppl 11:S98–S111CrossRef
6.
Zurück zum Zitat Hinchcliff ME, Beaumont JL, Carns MA, Podlusky S, Thavarajah K, Varga J et al (2015) Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis. J Rheumatol 42(1):64–72CrossRef Hinchcliff ME, Beaumont JL, Carns MA, Podlusky S, Thavarajah K, Varga J et al (2015) Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis. J Rheumatol 42(1):64–72CrossRef
7.
Zurück zum Zitat Mouthon L, Poiraudeau S, Vernon M, Papadakis K, Perchenet L, Khanna D (2020) Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU(R)) patient-reported outcome instrument. Arthritis Res Ther 22(1):3CrossRef Mouthon L, Poiraudeau S, Vernon M, Papadakis K, Perchenet L, Khanna D (2020) Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU(R)) patient-reported outcome instrument. Arthritis Res Ther 22(1):3CrossRef
8.
Zurück zum Zitat Christensen A, Khalique S, Cenac S, Fligelstone K, Mawdsley A, Frech T et al (2015) Systemic sclerosis related calcinosis: patients provide what specialists want to learn. J La State Med Soc 167(3):158–159PubMed Christensen A, Khalique S, Cenac S, Fligelstone K, Mawdsley A, Frech T et al (2015) Systemic sclerosis related calcinosis: patients provide what specialists want to learn. J La State Med Soc 167(3):158–159PubMed
9.
Zurück zum Zitat Sandler RD, Matucci-Cerinic M, Hughes M (2020) Musculoskeletal hand involvement in systemic sclerosis. Semin Arthritis Rheum 50(2):329–334CrossRef Sandler RD, Matucci-Cerinic M, Hughes M (2020) Musculoskeletal hand involvement in systemic sclerosis. Semin Arthritis Rheum 50(2):329–334CrossRef
10.
Zurück zum Zitat Young A, Namas R, Dodge C, Khanna D (2016) Hand impairment in systemic sclerosis: various manifestations and currently available treatment. Curr Treatm Opt Rheumatol 2(3):252–269CrossRef Young A, Namas R, Dodge C, Khanna D (2016) Hand impairment in systemic sclerosis: various manifestations and currently available treatment. Curr Treatm Opt Rheumatol 2(3):252–269CrossRef
11.
Zurück zum Zitat Health USDo, Human Services FDACfDE, Research, Health USDo, Human Services FDACfBE, Research et al (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79CrossRef Health USDo, Human Services FDACfDE, Research, Health USDo, Human Services FDACfBE, Research et al (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79CrossRef
12.
Zurück zum Zitat McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD (2011) Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res 11(2):163–169CrossRef McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD (2011) Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res 11(2):163–169CrossRef
13.
Zurück zum Zitat Rundell SD (2014) Including patient-reported outcomes and patient-reported resource-use questionnaires in studies. Acad Radiol 21(9):1129–1137CrossRef Rundell SD (2014) Including patient-reported outcomes and patient-reported resource-use questionnaires in studies. Acad Radiol 21(9):1129–1137CrossRef
Metadaten
Titel
Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?
verfasst von
Tracy M. Frech
John M. VanBuren
Emily Startup
Shervin Assassi
Elana J. Bernstein
Flavia V. Castelino
Lorinda Chung
Chase Correia
Jessica K. Gordon
Faye N. Hant
Laura Hummers
Dinesh Khanna
Nora Sandorfi
Ami A. Shah
Victoria K. Shanmugam
Virginia Steen
Luke Evnin
Publikationsdatum
23.10.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 3/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05467-9

Weitere Artikel der Ausgabe 3/2021

Clinical Rheumatology 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.